Evidence map›Paper›PMID 41589276›Full record

ArticleMedComm2026

Integrative Single-Cell Analysis Reveals Targetable Vacuole Membrane Protein 1-Mediated Mechanism of Tumor Angiogenesis in Glioblastoma.

Lei Jin, Bo Chen, Junbo Liao, Wenlong Guo, Zhiyuan Zhu, Salida Ali, Gilberto Ka-Kit Leung, Peng Wang, Karrie M Kiang

Abstract read
In one paragraph

Article in MedComm, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lei JinDepartment of Neurosurgery Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University Guangzhou China.
Bo ChenDepartment of Surgery School of Clinical Medicine LKS Faculty of Medicine The University of Hong Kong Hong Kong SAR China.
Junbo LiaoDepartment of Surgery School of Clinical Medicine LKS Faculty of Medicine The University of Hong Kong Hong Kong SAR China.
Wenlong GuoDepartment of Neurosurgery Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University Guangzhou China.
Zhiyuan ZhuDepartment of Surgery School of Clinical Medicine LKS Faculty of Medicine The University of Hong Kong Hong Kong SAR China.
Salida AliDepartment of Surgery School of Clinical Medicine LKS Faculty of Medicine The University of Hong Kong Hong Kong SAR China.
Gilberto Ka-Kit LeungDepartment of Surgery School of Clinical Medicine LKS Faculty of Medicine The University of Hong Kong Hong Kong SAR China.
Peng WangDepartment of Neurosurgery Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University Guangzhou China.
Karrie M KiangDepartment of Surgery School of Clinical Medicine LKS Faculty of Medicine The University of Hong Kong Hong Kong SAR China.ORCID https://orcid.org/0000-0002-4354-9648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vacuole membrane Protein 1 (VMP1) is widely known to be an important mediator in the formation of autophagosomes, playing a crucial role in macroautophagic processes. Emerging evidence suggests that VMP1 may have context-dependent functions across diverse cancer types and different tumor microenvironments, both within the context of autophagy and beyond. Here, using glioblastoma as a cancer model, we found that VMP1 can promote tumor growth independent of its autophagic functions. We observed significant upregulation of VMP1 in glioblastoma, which was correlated with poorer prognosis, and its ability to promote tumor growth without altering autophagic flux. Bulk, single-cell, and spatial transcriptomics analyses revealed that the pro-angiogenic markers were enriched in glioblastomas with high VMP1 expression. We further validated that overexpression of VMP1 would enhance angiogenesis through VEGFA-VEGFR2 signaling-mediated activation in endothelial cells. Treatment with bevacizumab, a monoclonal antibody against VEGFA, significantly inhibited VMP1-driven tumor growth and prolonged survival in mice. Our study thus uncovered non-autophagic functions of VMP1 as an important mediator in glioblastoma angiogenesis with the potential for therapeutic targeting.

Indexed as

angiogenesisautophagyglioblastomatransmembrane proteintumor microenvironment

Identifiers

PMID41589276
PMCPMC12832072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.